{
    "paper_id": "787ca9e573baf85cf5b860794bc4d9776ab60cd5",
    "metadata": {
        "title": "IMMUNOSUPPRESSION AND VIRUS INFECTION OF RODENTS 1",
        "authors": [
            {
                "first": "Neal",
                "middle": [],
                "last": "Nathanson",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Neurology University of Pennsylvania Medical Center Philadelphia",
                    "location": {
                        "country": "Pennsylvania"
                    }
                },
                "email": ""
            },
            {
                "first": "Francisco",
                "middle": [],
                "last": "Gonzalez-Scarano",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Neurology University of Pennsylvania Medical Center Philadelphia",
                    "location": {
                        "country": "Pennsylvania"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Immunosuppression is a standard part of the technical armamentarium used in experimental immunobiology and viral pathogenesis.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "I. INTRODUCTION"
        },
        {
            "text": "Over the past 20 years, an increasing number of methods have been developed to produce selective suppression of different elements of the host defensive response.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "I. INTRODUCTION"
        },
        {
            "text": "Macrophages, B cells, T cells, and their subsets may be deleted; alternatively their effector molecules, such as immunoglobulins or interferons, may be inactivated.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "I. INTRODUCTION"
        },
        {
            "text": "One potential consequence of the use of immunosuppression is the activation or potentiation of latent or intercurrent viral infections which may complicate and invalidate experimental studies. On the other hand, the deliberate use W.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "I. INTRODUCTION"
        },
        {
            "text": "\u00d1. holds a Javits award (NS 20904) and F. G-S. holds a TIDA (NS 00717) and a Harry Weaver Neuroscience Fellowship from the National Multiple Sclerosis Society. of immunosuppression complemented by immunoreplacement has enhanced our understanding of the role of various host defenses in acute and persistent viral infection. These two themes are the subject of this brief overview.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "I. INTRODUCTION"
        },
        {
            "text": "More detailed reviews are listed in the bibliography (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) .",
            "cite_spans": [
                {
                    "start": 53,
                    "end": 56,
                    "text": "(1)",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 57,
                    "end": 60,
                    "text": "(2)",
                    "ref_id": null
                },
                {
                    "start": 61,
                    "end": 64,
                    "text": "(3)",
                    "ref_id": null
                },
                {
                    "start": 65,
                    "end": 68,
                    "text": "(4)",
                    "ref_id": null
                },
                {
                    "start": 69,
                    "end": 72,
                    "text": "(5)",
                    "ref_id": null
                },
                {
                    "start": 73,
                    "end": 76,
                    "text": "(6)",
                    "ref_id": null
                },
                {
                    "start": 77,
                    "end": 80,
                    "text": "(7)",
                    "ref_id": null
                },
                {
                    "start": 81,
                    "end": 84,
                    "text": "(8)",
                    "ref_id": null
                },
                {
                    "start": 85,
                    "end": 88,
                    "text": "(9)",
                    "ref_id": null
                },
                {
                    "start": 89,
                    "end": 93,
                    "text": "(10)",
                    "ref_id": null
                },
                {
                    "start": 94,
                    "end": 98,
                    "text": "(11)",
                    "ref_id": null
                },
                {
                    "start": 99,
                    "end": 103,
                    "text": "(12)",
                    "ref_id": null
                },
                {
                    "start": 104,
                    "end": 108,
                    "text": "(13)",
                    "ref_id": null
                },
                {
                    "start": 109,
                    "end": 113,
                    "text": "(14)",
                    "ref_id": null
                },
                {
                    "start": 114,
                    "end": 118,
                    "text": "(15)",
                    "ref_id": null
                },
                {
                    "start": 119,
                    "end": 123,
                    "text": "(16)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "I. INTRODUCTION"
        },
        {
            "text": "Unwanted complications of immunosuppression are rarely published, so that the literature represents only the tip of the iceberg.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "A representative example was provided by an experience in our own laboratory (17) (18) (19) .",
            "cite_spans": [
                {
                    "start": 77,
                    "end": 81,
                    "text": "(17)",
                    "ref_id": null
                },
                {
                    "start": 82,
                    "end": 86,
                    "text": "(18)",
                    "ref_id": null
                },
                {
                    "start": 87,
                    "end": 91,
                    "text": "(19)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "An investigator at the Johns Hopkins University was developing treatment regimes for the maintenance of longterm immunological tolerance.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "While attempting to suppress the response of adult rats to sheep erythrocytes with cyclophosphamide, an alkylating agent which has a broad immunosuppressive activity, he noted that a small proportion of the animals developed hindlimb paralysis. Pathologic examination disclosed an unusual hemorrhagic lesion of the spinal cord.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "When homogenates of affected tissues were injected into suckling rats, a lethal disease was transmitted, with a more severe form of the same hemorrhagic encephalopathy. A parvovirus was isolated and identified as the causal agent; the isolate was called the HER (hemorrhagic encephalopathy of rats) strain of rat virus, a previously described parvovirus of rodents.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "The HER strain failed to cause disease when adult rats were infected intracerebrally. However, when potentiated by cyclophosphamide-induced immunosuppression, the infection progressed to paralysis in about 10% of the animals.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "It was never determined whether the original episode represented activation of a persistent latent infection or potentiation of an acute infection which happened to occur concomitantly with the administration of cyclophosphamide.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "Many Although, from the earliest days of animal virology it had been recognized that immunity protected against reinfection, it has only been 15 years since it was first shown that the immune response also plays a key role in recovery from primary viral infection. The initial experiments utilized methods, such as x-irradiation, cyclophosphamide, or anti-thymocyte serum, which caused temporary abrogation of both humoral and cell-mediated immunity (3-6).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "The hallmarks of potentiated infection were: 1) no alteration in virus replication during the first week or so (suppression-insensitive phase of infection); 2) a failure to clear virus during the second week (antigen-sensitive phase of infection); 3) replication to higher tissue titers than in immunocompetent animals; 4) enhancement of virusinduced pathology and increased mortality; 5) increased tissue titers of interferon.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "All of these observations (20-23, 30-35) supported the old concept that there was a race between the immune response and virus replication; anything which retarded immune induction would favor the virus.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "Furthermore, immunosuppression had no direct effect on the rate of viral replication but only on immune defenses.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "The major limitation of the early studies of immunosuppression was the lack of specificity of the methods employed (3-6, 36-38).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "Two complementary approaches have been taken to refine the experimental dissection of various components of the immune response: specific types of suppression (deletion techniques) and reconstitution with specific immune components (addition techniques). Each approach has its advantages and limitations. Deletion methods may be incomplete or only partially specific; addition methods may fail to mimic the physiologic response of intact animals and constitute therapy rather than reconstitution.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "A. Specific Immunodeletion T cell deletion may be accomplished with neonatal thymectomy; anti-thymocyte serum; adult thymectomy, x-irradiation, and bone marrow reconstitution (ATxBM); or through the use of homozygous nude (nu/nu) mice. However, such animals lack helper T cells and therefore cannot mount a normal B cell response.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "Furthermore, it is clear that different effector lymphocytes, such as cytotoxic T lymphocytes (39), NK cells (40), and ADCC-mediating K cells (41), can all play roles in anti-viral defense. This underlines the importance of specific deletion methods. The definition of T cell subjects and markers for them should make it possible to delete effector subsets of T cells, such as cytolytic T cells, with consequently improved specificity (42).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "One example of specific deletion is the use of anti-mu antiserum to delete IgM bearing B cells from neonatal animals, thus blocking the B cell arm of the immune response (43-46).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "When applied to a model of experimental rabies in the mouse, there was a failure to generate circulating antibody, with definite potentiation of infection; T cell populations and responses were intact (43).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "Administration of anti-interferon antiserum is another method \u00b7 of. considerable specificity.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "There is a large literature (1, 2, 8, 9) documenting the efficacy of interferon as therapy in ongoing acute experimental virus infection in normal animals.",
            "cite_spans": [
                {
                    "start": 28,
                    "end": 31,
                    "text": "(1,",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 32,
                    "end": 34,
                    "text": "2,",
                    "ref_id": null
                },
                {
                    "start": 35,
                    "end": 37,
                    "text": "8,",
                    "ref_id": null
                },
                {
                    "start": 38,
                    "end": 40,
                    "text": "9)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "However, it was never clear from such therapeutic trials whether interferon played a vital role in the recovery from infection in infected but otherwise unmanipulated animals.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "The application of anti-interferon antiserum has now provided convincing evidence that, at least in some experimental infections, neutralization of circulating interferon potentiates the virus (47-53).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "One action of interferon is to increase the activity of natural killer (NK) lymphocytes, which in turn can provide a nonspecific antiviral defense by attacking virus-infected targets (40, 54-57).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "Antiserum against as\u00edalo GM1, a neutral glycosphingolipid present on the surface of NK cells, can specifically deplete this lymphocyte population. Treatment with anti-asialo GM1 antiserum has been shown to potentiate viral infection (58,59).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "Complement plays an important ancillary role as a host defense, since in conjunction with specific antiviral antibody, it can lyse either virions or virus-infected cells (60).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "Decomplementation with cobra venom transiently lowers complement levels and partially potentiates viral infection (43,61).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "Other methods for specific deletion include reduction in macrophages with silica, anti-macrophage antiserum, or other treatments (62) (63) (64) ; or the use of cyclosporin which appears to retard T cell activation (65) (66) (67) (68) . Each of these methods has certain drawbacks such as partial efficacy, short duration, unwanted side effects, or inadequate specificity.",
            "cite_spans": [
                {
                    "start": 129,
                    "end": 133,
                    "text": "(62)",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 134,
                    "end": 138,
                    "text": "(63)",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 139,
                    "end": 143,
                    "text": "(64)",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 214,
                    "end": 218,
                    "text": "(65)",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 219,
                    "end": 223,
                    "text": "(66)",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 224,
                    "end": 228,
                    "text": "(67)",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 229,
                    "end": 233,
                    "text": "(68)",
                    "ref_id": "BIBREF7"
                }
            ],
            "ref_spans": [],
            "section": "II. INADVERTENT POTENTIATION OF VIRAL INFECTION: AN UNPLANNED COMPLICATION OF IMMUNOSUPPRESSION"
        },
        {
            "text": "Originally, reconstitution was accomplished with relatively primitive additions, such as polyclonal antiserum or unfractionated spleen, lymph node, or thymus cells. Those early experiments bolstered the conclusions from the suppression experiments and added conviction to hypotheses regarding the role of both B and T cells in the host defense against infectious agents (3-5, 69-74).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "B. Immune Reconstitution"
        },
        {
            "text": "The advent of monoclonal antibodies (11,75) has made it possible to refine this approach and examine the role of antibodies directed against individual virus proteins. From these more recent experiments (76-85) have come a number of significant conclusions: 1) antibodies against individual epitopes on viral proteins confer surprisingly effective protection against infection, in comparison to polyclonal antisera.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "B. Immune Reconstitution"
        },
        {
            "text": "This finding alone has major implications for the future development of vaccines and suggests that it may be realistic to develop oligopeptide vaccines directed against immunodominant epitopes. 2) As expected, there is a general correlation between neutralizing activity determined in cell culture assays and the protective efficacy of monoclonal antibodies.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "B. Immune Reconstitution"
        },
        {
            "text": "However, in some systems selected non-neutralizing monoclonal antibodies are also protective (86) . This may relate to the expression on virus-infected cells of viral epitopes which are not exposed on mature virions. 3) Monoclonal antibodies also permit the examination of the effect of other variables (87) , such as the immunoglobulin isotope, on protection.",
            "cite_spans": [
                {
                    "start": 93,
                    "end": 97,
                    "text": "(86)",
                    "ref_id": null
                },
                {
                    "start": 303,
                    "end": 307,
                    "text": "(87)",
                    "ref_id": "BIBREF18"
                }
            ],
            "ref_spans": [],
            "section": "B. Immune Reconstitution"
        },
        {
            "text": "The recent development of methods for the cloning of T cells and the culture of T cell lines (88) (89) (90) (91) (92) , has made it possible to study the effect of specific T cell subsets upon virus infection (93) (94) (95) (96) . Again, although the data are still limited, it is clear that certain effector subsets, such as cytolytic T cells, are capable of clearing virus or (in the case of virus-induced immunopathology) of mediating disease.",
            "cite_spans": [
                {
                    "start": 93,
                    "end": 97,
                    "text": "(88)",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 98,
                    "end": 102,
                    "text": "(89)",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 103,
                    "end": 107,
                    "text": "(90)",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 108,
                    "end": 112,
                    "text": "(91)",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 113,
                    "end": 117,
                    "text": "(92)",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 209,
                    "end": 213,
                    "text": "(93)",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 214,
                    "end": 218,
                    "text": "(94)",
                    "ref_id": null
                },
                {
                    "start": 219,
                    "end": 223,
                    "text": "(95)",
                    "ref_id": null
                },
                {
                    "start": 224,
                    "end": 228,
                    "text": "(96)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "B. Immune Reconstitution"
        },
        {
            "text": "It is now well established that certain viral diseases are mediated, not by a direct cytolytic effect of the agent, but by the immune response to the viral antigens. Among such diseases, lymphocytic choriomeningitis (LCM) of mice is the classical prototype, while acute hepatitis B is the most familiar human example (97). The salient aspects of such syndromes are that: 1) immunosuppression prevents disease but does not reduce virus tissue titers; 2) the virus is capable of replication and release from host cells without cytolysis (there are exceptions to this feature); 3) under certain conditions the virus can persist in infected cells or animals, often with little cellular or tissue destruction.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "IV. VIRUS-INITIATED IMMUNOPATHOLOGY"
        },
        {
            "text": "The essential features of LCM are worth recapitulating, since they illustrate the role of experimental suppression and immune reconstitution in documenting the ability of a virus to initiate lesions indirectly (12-15, 98-101). In adult mice, LCM virus, injected by the intracerebral route, causes an acute choriomeningitis with convulsions, resulting in death about seven days after infection. Nonspecific immunosuppressive treatments, such as x-irradiation or cyclophosphamide, will prevent this disease and also prevent the underlying lesions.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "IV. VIRUS-INITIATED IMMUNOPATHOLOGY"
        },
        {
            "text": "Nude mice and ATxBM mice are likewise protected, while \"B less\" mice treated with anti-mu antiserum are susceptible.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "IV. VIRUS-INITIATED IMMUNOPATHOLOGY"
        },
        {
            "text": "Virus titers in suppressed and protected animals are high and, in fact, these mice become longterm virus carriers.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "IV. VIRUS-INITIATED IMMUNOPATHOLOGY"
        },
        {
            "text": "Reconstitution experiments (98, 99, 102) show that antiviral antiserum will not reconstitute disease, while immune T cells (102), or cytolytic T cell clones (94,95), will induce acute disease when transferred into syngeneic recipients.",
            "cite_spans": [
                {
                    "start": 27,
                    "end": 31,
                    "text": "(98,",
                    "ref_id": null
                },
                {
                    "start": 32,
                    "end": 35,
                    "text": "99,",
                    "ref_id": null
                },
                {
                    "start": 36,
                    "end": 40,
                    "text": "102)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "IV. VIRUS-INITIATED IMMUNOPATHOLOGY"
        },
        {
            "text": "Studies of the arenaviruses (of which LCM is the prototype) have extended these classical studies in several directions (15).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "IV. VIRUS-INITIATED IMMUNOPATHOLOGY"
        },
        {
            "text": "Arenaviruses, in addition to causing inflammatory lesions, can also cause acute tissue destruction of specific organs, such as the cerebellum or liver (103, 105).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "IV. VIRUS-INITIATED IMMUNOPATHOLOGY"
        },
        {
            "text": "Persistent viremia is usually accompanied by continuous synthesis of antiviral antibodies and the resulting immune complexes, over a period of months to years, produce chronic and eventually fatal glomerulonephritis (106, 107) .",
            "cite_spans": [
                {
                    "start": 216,
                    "end": 221,
                    "text": "(106,",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 222,
                    "end": 226,
                    "text": "107)",
                    "ref_id": "BIBREF29"
                }
            ],
            "ref_spans": [],
            "section": "IV. VIRUS-INITIATED IMMUNOPATHOLOGY"
        },
        {
            "text": "Persistently infected animals can be cleared of their virus by adoptive immunization with virus-specific immune T cells (108) , and this can be accomplished by cloned (110); the post-infectious demyelination caused by canine distemper virus (CDV); rabies early death syndrome (111) (112) (113) ; dengue hemorrhagic fever (101); respiratory syncytial virus pneumonia; possibly some of the hemorrhagic fever-shock syndromes caused by arenaviruses (Argentine hemorrhagic fever, Bolivian hemorrhagic fever, Lassa fever); and possibly hemorrhagic fever renal syndrome (HFRS) caused by hantaviruses, such as Korean hemorrhagic fever virus (114) .",
            "cite_spans": [
                {
                    "start": 120,
                    "end": 125,
                    "text": "(108)",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 276,
                    "end": 281,
                    "text": "(111)",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 282,
                    "end": 287,
                    "text": "(112)",
                    "ref_id": null
                },
                {
                    "start": 288,
                    "end": 293,
                    "text": "(113)",
                    "ref_id": null
                },
                {
                    "start": 633,
                    "end": 638,
                    "text": "(114)",
                    "ref_id": "BIBREF38"
                }
            ],
            "ref_spans": [],
            "section": "IV. VIRUS-INITIATED IMMUNOPATHOLOGY"
        },
        {
            "text": "One important concept that has emerged from the experimental studies described above is the dual role of the immune response. The immune response can both act as a host defense and cause disease, and the mechanisms involved are identical.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "A. Dual Role of the Immune Response"
        },
        {
            "text": "Thus, the attack on virus-infected target cells, by either antibody and complement or by cytolytic T cells, simultaneously destroys host tissue and removes the sites of viral replication.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "A. Dual Role of the Immune Response"
        },
        {
            "text": "Likewise, the binding of antibody to free infectious virions, both neutralizes and forms immune complexes which potentially can cause vasculitis and nephritis.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "A. Dual Role of the Immune Response"
        },
        {
            "text": "The kinetics of virus replication and immune induction may together determine which of these effects predominates.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "A. Dual Role of the Immune Response"
        },
        {
            "text": "Thus, if the immune response is sufficiently brisk, the number of infected cells available as targets is limited and the destruction of host tissue is minimal. Conversely, if many cells are infected, their removal by immune attack can produce severe or lethal lesions.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "A. Dual Role of the Immune Response"
        },
        {
            "text": "These concepts have been amply documented in studies of LCMV infection of mice.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "A. Dual Role of the Immune Response"
        },
        {
            "text": "For instance, it is possible to immunize against LCMV infection and thereby protect against an immunopathology (6,115,116 ) .",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 111,
                    "end": 123,
                    "text": "(6,115,116 )",
                    "ref_id": null
                }
            ],
            "section": "A. Dual Role of the Immune Response"
        },
        {
            "text": "However, if mice are inadequtely immunized, instead of protection there occurs an accelerated form of the immunopathology. Likewise, incomplete post-exposure (post-infection) immunization in experimental rabies can cause \"early death\" in some animals, which die before any of their infected but unimmunized counterparts (111) (112) (113) .",
            "cite_spans": [
                {
                    "start": 320,
                    "end": 325,
                    "text": "(111)",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 326,
                    "end": 331,
                    "text": "(112)",
                    "ref_id": null
                },
                {
                    "start": 332,
                    "end": 337,
                    "text": "(113)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "A. Dual Role of the Immune Response"
        },
        {
            "text": "The dual role of the immune response is not merely an immunological curiosity, since it is seen very clearly in human hepatitis B (97). Here, some infected subjects develop a brisk immune response and clear their infection rapidly, with minimal or no clinical disease; others fail to develop an adequate response against the HBs antigen, become persistent virus carriers, but are clinically healthy; only those persons who have extensive infection prior to an immune response to HBs antigen, develop severe hepatitis in the process of clearing the infection.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "A. Dual Role of the Immune Response"
        },
        {
            "text": "The proposal that virus infection could initiate an auto-immune response has been suggested repeatedly in the past.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "B. Virus-induced Autoimmunity"
        },
        {
            "text": "Only recently, however, have experimental data evolved to support this hypothesis (16). The advent of B cell hybridoma technology has made it possible to determine whether specific antibodies to viral proteins might also recognize epitopes on self proteins (sometimes called molecular mimicry).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "B. Virus-induced Autoimmunity"
        },
        {
            "text": "It now appears that, if a sufficient number of antibodies against any virus are examined, a small but finite number will also react with epitopes present in one or multiple organs (117) (118) (119) (120) (121) (122) (123) (124) . Furthermore, infections of mice with certain viruses, such as reovirus, result in an autoimmune disease which can be prevented by immunosuppression (118, 125) .",
            "cite_spans": [
                {
                    "start": 180,
                    "end": 185,
                    "text": "(117)",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 186,
                    "end": 191,
                    "text": "(118)",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 192,
                    "end": 197,
                    "text": "(119)",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 198,
                    "end": 203,
                    "text": "(120)",
                    "ref_id": "BIBREF44"
                },
                {
                    "start": 204,
                    "end": 209,
                    "text": "(121)",
                    "ref_id": "BIBREF45"
                },
                {
                    "start": 210,
                    "end": 215,
                    "text": "(122)",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 216,
                    "end": 221,
                    "text": "(123)",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 222,
                    "end": 227,
                    "text": "(124)",
                    "ref_id": "BIBREF48"
                },
                {
                    "start": 378,
                    "end": 383,
                    "text": "(118,",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 384,
                    "end": 388,
                    "text": "125)",
                    "ref_id": "BIBREF49"
                }
            ],
            "ref_spans": [],
            "section": "B. Virus-induced Autoimmunity"
        },
        {
            "text": "Results of this type make it plausible that an acute or persistent virus infection could give rise to an autoimmune process.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "B. Virus-induced Autoimmunity"
        },
        {
            "text": "Recently, a possible example of virus-initiated autoimmunity has been reported in a murine model of virusinduced demyelination (126) .",
            "cite_spans": [
                {
                    "start": 127,
                    "end": 132,
                    "text": "(126)",
                    "ref_id": "BIBREF50"
                }
            ],
            "ref_spans": [],
            "section": "B. Virus-induced Autoimmunity"
        },
        {
            "text": "Rats infected with mouse hepatitis virus (MHV) developed demyelinating lesions about one month later. Some of these animals had spinal cord lesions resembling experimental allergic encephalitis (EAE). When spleen or lymph node cells from such rats were cultured in vitro with myelin basic protein (BP), they proliferated as measured by thymidine incorporation.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "B. Virus-induced Autoimmunity"
        },
        {
            "text": "These antigendriven cells, when transferred into a syngeneic (but not an allogeneic) recipient, induced EAE, in about one week. Several controls indicated that MHV was not being transferred with the cells, and the one week interval was too short for virus-induced demyelination. An inescapable conclusion is that every attempt must be made to utilize animals obtained from sources which monitor for viruses and which are relatively virus-free\u00b7 Perhaps a greater problem is the need to isolate such animals from enzootic agents in the experimenters 1 own facility. Our recent experience in a university research facility is that these are very real problems.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "B. Virus-induced Autoimmunity"
        },
        {
            "text": "A barrier facility is probably necessary in most institutions to protect newly introduced animals from rapidly acquiring infections. In addition, minibarriers provided by the use of isolators and filter top cages are important adjuncts. Also, the institution must monitor constantly to determine whether enzootic agents can be excluded from clean rodents imported into the facility.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "B. Virus-induced Autoimmunity"
        },
        {
            "text": "Finally, it is likely that certain institutions fail to meet these criteria; such institutions are probably inappropriate settings for many immunological and viral studies conducted in animals. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "B. Virus-induced Autoimmunity"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Adverse effects of interferon in virus infection, autoimmune diseases and acquired immunodeficiency",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Vilcek",
                    "suffix": ""
                }
            ],
            "year": 1984,
            "venue": "Prog. Med. Virol",
            "volume": "30",
            "issn": "",
            "pages": "62--77",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Selective effects of antimacrophage serum, silica, and antilymphocyte serum on pathogenesis of herpes virus infection of young adult mice",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Zisman",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "S"
                    ],
                    "last": "Hirsch",
                    "suffix": ""
                },
                {
                    "first": "Allcison",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1969,
            "venue": "Journal of Immunology",
            "volume": "104",
            "issn": "",
            "pages": "1155--59",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Modifications by sodium aurothio-malate of the expression of virulence by defined strains of Semliki Forest virus",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Allner",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Bradish",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Fitzgerald",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Nathanson",
                    "suffix": ""
                }
            ],
            "year": 1974,
            "venue": "J. Gen. Virol",
            "volume": "24",
            "issn": "",
            "pages": "221--249",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Use of silica to identify host mechanisms involved in suppression of established Friend virus leukemia",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Wirth",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "H"
                    ],
                    "last": "Levy",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "F"
                    ],
                    "last": "Wheelock",
                    "suffix": ""
                }
            ],
            "year": 1976,
            "venue": "J. Immunol",
            "volume": "117",
            "issn": "",
            "pages": "2124--2154",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Beneficial effect of cyclosporin A on the lymphocytic choriomengitis virus infection in mice",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "F"
                    ],
                    "last": "Saron",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Shidani",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Guillon",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Truffa-Bachi",
                    "suffix": ""
                }
            ],
            "year": 1984,
            "venue": "Eur. J. Immunol",
            "volume": "14",
            "issn": "",
            "pages": "1064--66",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Modulation by cyclosporin A of murine natural resistance against herpes simplex virus infection. I. Interference with the susceptibility to herpes simplex virus infection",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Armerding",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Scriba",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Hren",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Rossiter",
                    "suffix": ""
                }
            ],
            "year": 1982,
            "venue": "Antiviral Res",
            "volume": "2",
            "issn": "",
            "pages": "3--11",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Cyclosporin A-usefulness, risks, and mechanism of action",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Britton",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Palacios",
                    "suffix": ""
                }
            ],
            "year": 1982,
            "venue": "Immunol. Rev",
            "volume": "65",
            "issn": "",
            "pages": "5--22",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Cyclophilin: a specific cytosolic binding protein for cyclosphorin A",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "E"
                    ],
                    "last": "Hanschumacher",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "W"
                    ],
                    "last": "Harding",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Rice",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "J"
                    ],
                    "last": "Drugge",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "W"
                    ],
                    "last": "Speicher",
                    "suffix": ""
                }
            ],
            "year": 1984,
            "venue": "Science",
            "volume": "226",
            "issn": "",
            "pages": "544--590",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Suppressor T cells for delayed-type hypersensitivity to Japanese encephalitis virus",
            "authors": [],
            "year": null,
            "venue": "Immunology",
            "volume": "52",
            "issn": "",
            "pages": "395--402",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes. Infect, and Immun",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "S"
                    ],
                    "last": "Larsen",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "G"
                    ],
                    "last": "Russell",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "T"
                    ],
                    "last": "Rouse",
                    "suffix": ""
                }
            ],
            "year": 1983,
            "venue": "",
            "volume": "41",
            "issn": "",
            "pages": "197--204",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Mechanism of recovery from systemic herpes simplex virus infection. I. Comparative effectiveness of antibody and reconstitution of immune spleen cells on immunosuppressed mice",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Worthington",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Conliffe",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Baron",
                    "suffix": ""
                }
            ],
            "year": 1980,
            "venue": "J. Infect. Dis",
            "volume": "142",
            "issn": "",
            "pages": "163--74",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "An adoptive cell transfer system for the evaluation of immunity to herpes simplex virus in mice",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Favila",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "L"
                    ],
                    "last": "Howes",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "A"
                    ],
                    "last": "Taylor",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "A"
                    ],
                    "last": "Mitchison",
                    "suffix": ""
                }
            ],
            "year": 1982,
            "venue": "Clin. Exp. Immunol",
            "volume": "48",
            "issn": "",
            "pages": "307--321",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "E2 glycoprotein of semliki Forest virus can protect mice from lethal encephalitis",
            "authors": [],
            "year": null,
            "venue": "J. Gen. Virol",
            "volume": "64",
            "issn": "",
            "pages": "1405--1413",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Balachandran",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Bacchetti",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "E"
                    ],
                    "last": "Rawls",
                    "suffix": ""
                }
            ],
            "year": 1982,
            "venue": "Infection and Immunity",
            "volume": "37",
            "issn": "",
            "pages": "1132--1169",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Use of monoclonal antibodies for analysis of antibodydependent immunity to ocular herpes simplex virus type 1",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "T"
                    ],
                    "last": "Rector",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "N"
                    ],
                    "last": "Lausch",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "E"
                    ],
                    "last": "Oakes",
                    "suffix": ""
                }
            ],
            "year": 1982,
            "venue": "Infection and Immunity",
            "volume": "38",
            "issn": "",
            "pages": "168--174",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Non-neutralizing monoclonal antibodies can prevent lethal alpha virus encephalitis",
            "authors": [],
            "year": null,
            "venue": "Nature",
            "volume": "297",
            "issn": "",
            "pages": "70--72",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Inductin of subacute murine measles encephalitis by monoclonal antibody to virus haemagglutinin",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "W"
                    ],
                    "last": "Rammohan",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "F"
                    ],
                    "last": "Mcfarland",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "E"
                    ],
                    "last": "Mcfarlin",
                    "suffix": ""
                }
            ],
            "year": 1981,
            "venue": "Nature",
            "volume": "290",
            "issn": "",
            "pages": "588--89",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Cloning of functional T lymphocytes l!n_: Concepts in viral pathogenesis",
            "authors": [
                {
                    "first": "Jean",
                    "middle": [],
                    "last": "Charles",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Macdonald",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "R"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1984,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Specificity of in vitro cytotoxic clones directed againt vesicular stomatitis virus",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "L"
                    ],
                    "last": "Rosenthal",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "B A"
                    ],
                    "last": "Oldstone",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Hengartner",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "M"
                    ],
                    "last": "Zinkernagel",
                    "suffix": ""
                }
            ],
            "year": 1983,
            "venue": "J. Immunol",
            "volume": "131",
            "issn": "",
            "pages": "475--78",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Biology of clone cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Byrne",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Ahmed",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "B A"
                    ],
                    "last": "Oldstone",
                    "suffix": ""
                }
            ],
            "year": 1984,
            "venue": "J. Immunol",
            "volume": "133",
            "issn": "",
            "pages": "433--472",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Characterization of the murine Th response to influenza virus hemagglutinin: evidence for three major specificities",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Hurwitz",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Heberkkatz",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Hackett",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Gerhard",
                    "suffix": ""
                }
            ],
            "year": 1984,
            "venue": "J. Immunol",
            "volume": "133",
            "issn": "",
            "pages": "3371--77",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Production and characterization of T cell clones specific for mouse hepatitis virus stain JHM: in vivo and in vitro analysis",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "G"
                    ],
                    "last": "Woodward",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Matsushima",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Frelinger",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Stahlman",
                    "suffix": ""
                }
            ],
            "year": 1984,
            "venue": "J. Immunol",
            "volume": "133",
            "issn": "",
            "pages": "1016--1037",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virusspecific and H-2-restricted cytotoxic T lymphocytes",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "K"
                    ],
                    "last": "Sethi",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Omata",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "E"
                    ],
                    "last": "Schneweis",
                    "suffix": ""
                }
            ],
            "year": 1983,
            "venue": "J. Gen. Virol",
            "volume": "64",
            "issn": "",
            "pages": "443--490",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "neonatal rats: protective effect of immunosuppression with anti-lymphoid serum",
            "authors": [],
            "year": null,
            "venue": "Infect, and Immunol",
            "volume": "10",
            "issn": "",
            "pages": "449--502",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "The effect of neonatal thymectomy on Tamiami, virus-induced central nervous system disease",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "M"
                    ],
                    "last": "Friedman",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "H"
                    ],
                    "last": "Gilden",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "Roosa",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Nathanson",
                    "suffix": ""
                }
            ],
            "year": 1975,
            "venue": "Journal of Neuropath, and Exp. Neurol",
            "volume": "34",
            "issn": "",
            "pages": "159--166",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Virus-induced immune complex formation and disease: definition, regulation",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "B A"
                    ],
                    "last": "Oldstone",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 1984,
            "venue": "Concepts in viral pathogenesis",
            "volume": "",
            "issn": "",
            "pages": "201--210",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Effect of immunosuppression on chronic LCM virus",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "E"
                    ],
                    "last": "Hoffsten",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "J"
                    ],
                    "last": "Dixon",
                    "suffix": ""
                }
            ],
            "year": 1973,
            "venue": "J. of Experimental Medicine",
            "volume": "138",
            "issn": "",
            "pages": "887--94",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Virus elimination in acute lymphocytic chorimeningitis virus infection. Correlation with virus-specific delayed-type hypersensitivity rather than cytotoxicity",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "R"
                    ],
                    "last": "Thomsen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Volkert",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Bro-Jorgensen",
                    "suffix": ""
                }
            ],
            "year": 1983,
            "venue": "Scand. J. Immunol",
            "volume": "17",
            "issn": "",
            "pages": "489--95",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Virus-induced demyelination In: Concepts in viral pathogenesis",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "W"
                    ],
                    "last": "Lampert",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Rodriguez",
                    "suffix": ""
                }
            ],
            "year": 1983,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "260--268",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Pathogenesis of borna disease in rats: Immune-mediated viral ophthalmoencephalopathy causing blindness and behavioral abnormalities",
            "authors": [
                {
                    "first": "0",
                    "middle": [],
                    "last": "Narayan",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Herzog",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Frese",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Scheefers",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Rott",
                    "suffix": ""
                }
            ],
            "year": 1983,
            "venue": "J. of Infectious Diseases",
            "volume": "142",
            "issn": "",
            "pages": "305--315",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Acute rabies death mediated by antibody",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Prabhakar",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Nathanson",
                    "suffix": ""
                }
            ],
            "year": 1981,
            "venue": "Nature",
            "volume": "290",
            "issn": "",
            "pages": "590--591",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Immunopathologic aspects of infection with Lagos bat virus of the rabies serogroup",
            "authors": [],
            "year": null,
            "venue": "J. Immunol",
            "volume": "112",
            "issn": "",
            "pages": "260--265",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "Dual role of the immune response in street rabies virus infection of mice",
            "authors": [],
            "year": null,
            "venue": "Infect. Immun",
            "volume": "35",
            "issn": "",
            "pages": "213--221",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Hemorrhagic fever viruses",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Peters",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Johnson",
                    "suffix": ""
                }
            ],
            "year": 1984,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "325--327",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "The timing of the immune response in relation to virus growth determines the outcome of the LCM infection",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "R"
                    ],
                    "last": "Thomsen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Volkert",
                    "suffix": ""
                },
                {
                    "first": "Marker",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1979,
            "venue": "Acta. Pathol. Microbiol. Scand",
            "volume": "87",
            "issn": "",
            "pages": "47--54",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Immune responses to LCM virus infection \u00b1\u03b7_ vivo and in vitro. Mechanisms of immune-mediated disease",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "116\u00b7 Cole",
                    "suffix": ""
                },
                {
                    "first": "Johnson",
                    "middle": [],
                    "last": "A\u00b7",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "D"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1975,
            "venue": "Bull World Health Organ",
            "volume": "52",
            "issn": "",
            "pages": "465--470",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Infection with vaccinia favors the selection of hybridomas synthesizing autoantibodies against intermediate filaments, one of them cross-reacting with virus hemagglutinin",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Dales",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "S"
                    ],
                    "last": "Fujinami",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "B A"
                    ],
                    "last": "Oldstone",
                    "suffix": ""
                }
            ],
            "year": 1983,
            "venue": "J. Immunol",
            "volume": "131",
            "issn": "",
            "pages": "1546--53",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Virus-induced diabetes mellitus: autoimmunity and polyendocrine disease prevented by immunosuppression",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Onodera",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [
                        "R"
                    ],
                    "last": "Ray",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "A"
                    ],
                    "last": "M\u00ealez",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Suzuki",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Toniolo",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "L"
                    ],
                    "last": "Notkins",
                    "suffix": ""
                }
            ],
            "year": 1982,
            "venue": "Nature",
            "volume": "297",
            "issn": "",
            "pages": "66--68",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "Autoimmunity induced by syngeneic membranes carrying irreversibly adsorbed paramyxovirus. Infect, and Immun",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "D"
                    ],
                    "last": "Eaton",
                    "suffix": ""
                }
            ],
            "year": 1980,
            "venue": "",
            "volume": "27",
            "issn": "",
            "pages": "855--861",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Molecular mimicry in virus infection: cross reaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "S"
                    ],
                    "last": "Fujinami",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "B A"
                    ],
                    "last": "Oldstone",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Wroblewska",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "E"
                    ],
                    "last": "Frankel",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Koprowski",
                    "suffix": ""
                }
            ],
            "year": 1983,
            "venue": "Proc. Nati. Acad. Sei",
            "volume": "80",
            "issn": "",
            "pages": "2346--50",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "Cellular proteins reactive with monoclonal antibodies directed against simian virus 40 T-antigen",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Crawford",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Leppard",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "K\u00b7",
                    "suffix": ""
                },
                {
                    "first": "D\u00b7",
                    "middle": [],
                    "last": "Lane",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Harlow",
                    "suffix": ""
                }
            ],
            "year": 1982,
            "venue": "J. Virol",
            "volume": "42",
            "issn": "",
            "pages": "612--632",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "Virus-induced autoimmunity: monoclonal antibodies that react with endocrine tissues",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Haspel",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "V\u00b7",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Onodera",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "S"
                    ],
                    "last": "Prabhakar",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Horita",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Suzuki",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Notkins",
                    "suffix": ""
                }
            ],
            "year": 1983,
            "venue": "Science",
            "volume": "220",
            "issn": "",
            "pages": "304--310",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "Three monoclonal antibodies against measles virus F protein cross-react with cellular stress proteins",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Sheshberadaran",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Norrby",
                    "suffix": ""
                }
            ],
            "year": 1984,
            "venue": "J. Virol",
            "volume": "52",
            "issn": "",
            "pages": "995--1004",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "Virus-induced autoimmunity: Monoclonal antibodies that react with endocrine tissues",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Churchill",
                    "suffix": ""
                }
            ],
            "year": 1982,
            "venue": "Science",
            "volume": "220",
            "issn": "",
            "pages": "304--310",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "Virus-induced diabetes mellitus. XX. Polyendocrinopathy and autoimmunity",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Onodera",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Toniolo",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [
                        "R"
                    ],
                    "last": "Ray",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "B"
                    ],
                    "last": "Jenson",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "A"
                    ],
                    "last": "Knazek",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "L"
                    ],
                    "last": "Notkins",
                    "suffix": ""
                }
            ],
            "year": 1981,
            "venue": "J. Exp. Med",
            "volume": "153",
            "issn": "",
            "pages": "1457--73",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Watanabe",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Wege",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Ter Meulen",
                    "suffix": ""
                }
            ],
            "year": 1983,
            "venue": "Nature",
            "volume": "305",
            "issn": "",
            "pages": "150--153",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": ", N. and Cole, G.A. (1970). Immunosuppression and experimental virus infection of the nervous system. Adv. Virus Res. 16: 397-448. 4. Nathanson, N. and Cole G.A. (1971). Immunosuppression: a means to assess the role of the immune response in acute virus infections. Fed. Proc. 30: 1822-1830. 5. Nathanson, N. and Cole, G.A. (1975). Immunosuppression and experimental viral infection: the dual role of the immune response. 1\u038f_: The immune system and infectous diseases, edited by E. Neter, Karger, Basel, 76-94. 6. Nathanson, N., Monjan, A.A., Panitch, H.S., Johnson, E.D., Petursson, G., and Cole, G.A. (1975). Virusinduced cell-mediated immunopathological disease. In: Viral immunology and immunopathology, edited by A.L. Notkins, Academic Press, N.Y. 357-391. 7. Fauconnier, B. (1981). Effect of anti-interferon antibody on infections of animals. Tex. Rep. Biol. Med. 41: 522-5. 8. Vilcek, J., Gresser, I., and Merigan, T.C., eds. (1980). Regulatory functions of interferons. Ann. NY Acad. Sei. 350: 1-641. 9. Stanton, G.J., and Baron, S. (1984). Interferon and viral pathogenesis. In: Concepts in viral pathogenesis, edited by A.L., Notkins, and M.B.A. Oldstone, Springer-Verlag, New York, 3-10. 10. Mims, C.A. (1974). Factors in the mechanism of persistence of viral infections. Prog. Med. Virol. 18: 1-14. 11. Carter, M., ter Meulen, V. (1984). The application of monoclonal antibodies in the study of viruses. Adv. Virus Res. 29: 95-130. 12. Cole, G.A., and Nathanson, N. (1974). Lymphocytic choriomeningitis. Prog. Med. Virology, 18: 94-110. 13. Cole, G.A., Gilden, D.H., Monjan, A.A., and Nathanson, N. (1971). Lymphocytic choriomeningitis virus. Pathogenesis of acute central nervous system disease. Fed. Proc. 30: 1831-41. 14. Lehmann-Grube, F. (1973). Lymphocytic choriomeningitis virus and other arenaviruses. Virology Monographs. 10: 1-73.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "autoimmunity. In_: Concepts in viral pathogenesis, edited by A.L. Notkins, and M.B.A. Oldstone, Springer-Verlag, New York. 210-215. 17. Nathanson, N., Cole, G.A., Santos, G.W., Squire, R.A., and Smith, K.O. (1970). Viral hemorrhagic encephalopathy of rats. I. Isolation, identification, and properties of the HER strains of rat virus. Am. J. Epidemiol. 91: 328-338. 18. Cole, G.A., Nathanson, N, Rivet, H. (1970). Viral hemorrhagic encephalopathy of rats. II. Pathogenesis of central nervous system lesions. Am. J. Epidemol. 91: 339-350. 19. Baringer, J.R., and Nathanson, N. (1972). Parvovirus hemorrhagic encephalopathy of rats. Electron microscopic observations of the vascular lesionsl. Lab. Invest. 27: 514-522. 20. Anderson, M.J., Pattison, J.R., Cureton, R.J., Argent, S., and Heath R.B. (1980). The role of host responses in the recovery of mice from Sendai virus infection. J. Gen. Virol. 46: 373-9. 21. Levy-Lebland, E. and Dupuy, J.M. (1977). Neonatal susceptibility to MHV3 infection in mice. I. Transfer of resistance. J. Immunol. 118: 1219-22. 22. Roos, R.P., Wollman, R., Variakojis, D., and Arnason, B.G. (1982). The effect of short-term and chronic immunosuppression on Theiler's virus demyelination. J. Neuroimmunol. 2: 223-34. 23. Lipton, H.L., and Dal Conto, M.C. (1976). Theiler f s virus-induced demyelination: prevention by immunosuppression. Science 192: 62-64. 24. Openshaw, H., Asher, L.V., Wohlenberg, C, Sekiazawa, T., and Notkins, A.L. (1979). Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation. J. Gen. Virol. 44: 205-15. 25. Shanley, J.D., Jordan, M.C, Cook, M.L., and Stevens J.G. (1979). Pathogenesis of reactivated latent murine cytomegalovirus infection. Am. J. Path. 95: 67-80. 26. Mayo, D, Armstrong, J.A., and Ho, M. (1978). Activation of latent murine cytomegalovirus infection: cocultivation, cell transfer, and the effect of immunosuppression. J. Infect. Dis. 138: 890-6. 27. Jordan, M.C., Tqakagi, J.L., and Stevens, J.G. (1982). Activation of latent murine cytomegalovirus in vivo and jLn_ vitro: a pathogenetic role for acute infection. J. Infect. Dis. 145: 699-705. 28. Sekizawa, T., and Openshaw, H. (1984). Encephalitis resulting from reactivation of latent herpes simplex virus in mice. J. Virol. 50: 263-66. 29. Mayo, U.R. and Rapp, F. (1980). Leukemia reactivates mouse cytomegalovirus. J. Gen. Virol. 51: 410-4. 30. Selgrade, M.K., Daniels, M.J., Hu, P.C., Miller, F.J., and Graham, J.A. (1982). Effects of immunosuppression with cyclophosphamide on acute murine cytomegalovirus infection and virus-augmented natural killer cell activity. Infect, and Immunity. 38: 1046-55. 31. Smith. J.S. (1981). Mouse model for abortive rabies infection of the central nervous system. Infect, and Immunity. 31: 297-308. 32. Jubelt, B., Gallez-Hawkins, G., Narayon, 0., and Johnson, R.T. (1980). Pathogenesis of human poliovirus infection in mice. I. Clinical and pathological studies. J. Neuropath. Exp. Neurol., 39: 138-48. 33. Jubelt, B., and Meagher, J.B. (1984). Poliovirus infection of cyclophosphamide-treated mice results in persistence and late paralysis. I. Clinical, pathologic, and immunologie studies. Neurology, 34: 494-93. 34.' Jubelt, B., and Meagher, J.B. (1984). Poliovirus infection of cyclophosphamide-treated mice results in persistence and late paralysis. II. Virologie studies. Neurology, 34: 494-99. 35. Patel, J.R. (1979). Invasion of mouse brain by Mount Elgon bat virus. J. Gen. Virol. 44: 587-97. 36. Camenga, D., Nathanson, N., and Cole G.A. (1974). Cyclophosphamide-potentiated West Nile encephalitis: relative influence of cellular and humoral factors. J. Inf. Dis. 130: 634-41. 37. Prabhakar, B.S., Fischman, H.R., and Nathanson, N. (1981). Recovery from experimental rabies by adoptive transfer of immune cells. J. Gen Virol. 56: 25-31. 38. Nahmias, A.J., Hirsch, M.S., Kramer, J.H., and Murphy, F.A. (1969). Effect of antithymocyte serum on herpes virus hominis (type 1) infection in adult mice. Proc. Soc. Biol. Med. 132: 6965-98. 39. Doherty, P.C. and R.M. Zinkernagel. (1984). MHC restriction and cytotoxic T lymphocytes. In: Concepts in viral pathogenesis, edited by A.L. Notkins and M.B.A. Oldstone, Springer-Verlag, New York. 53-57. 40. Casali, P. and Trinchieri, G. (1984). Natural killer cells in viral infection in Concepts in viral pathogenesis, edited by A.L. Notkins and M.B.A. Oldstone, Springer-Verlag, New York, 11-19. 41. Perlmann, P. (1984). Antibody-dependent cellular cytotoxicity (ADCC) mediated by human killer lymphocytes (K-cells). In; Concepts in viral pathogenesis, edited by A.L. Notkins and M.B.A. Oldstone, Springer-Verlag, New York, 58-64. 42. Cobbold, S.P., Jayasuriya, A., Nash, A., Prospero, T.D., Waldman, H. (1984). Therapy with monoclonal antibodies by elimination of T-cell subsets _in_ vivo. Nature. 312: 548-51. 43. Miller, A., Morse, E.H. Ill, Winkelstein, J., and Nathanson, N. (1977). The role of antibody in recovery from experimental rabies. J. Immunol. 121: 321-6. 44. Kris, R.M., Asofsky, R., Evans, CM., Small, P.A., Jr. (1985). Protection and recovery in influenza virus-infected mice immunosuppressed with anti-IgM. J. Immunol. 134: 1230-35. 45. Jordan, C, Baron, S., Dianzani, F., Barber, J., Stanton, G.J. (1983). Ocular herpes simplex virus infection is diminished by depletion of B lymphocytes. J. Immunol. 131: 1554-57. 46. Hoffman, Robbins, D.S., Morse, H.C., III. (1984). Role of immunity in age-related resistance to paralysis after murine leukemia virus infection. J. Virol. 52: 734-38. 47. Hoshno, A., Takenaka, H., Mizukoshi, 0., Imanishi, J., Kishida, T., and Tovey, M.G. (1983). Effect of antiinterferon serum of influenza virus infection in mice. Antiviral Res. 31: 59-65. 48. Zawatzky, R., Gresser, DeMaeyer, E., and Kirchner, H. (1982). The role of interferon in the resistence of C57BL/6 mice to various doses of herpes simplex virus type 1. J. Infect. Dis. 146: 405-10. 49. Grundy, J.E., Trapman, J., Allan, J.E., Shellam, G.R., and Melief, C.J. (1982). Evidence for a protective role of interferon in resistance to murine cytomegalovirus and its control by non-H-2-linked genes. Infect, and Immun. 37: 143-150. 50. Blank, K. J. and Murasko, D.M. (1981). Effect of anti-interferon serum on Friend virus infection and Fv-1-mediated resistance. J. Interferon Res. 1: 437-42. 51. Haller, 0., Arnheiter, H., Horisberger, M.A., Gresser, I., and Lindenmann, J. (1980). Interaction between interferon and host genes in antiviral defense. Ann. N.Y. Acad. Sei. 350: 58-65. 52. Riviere, Y., Gresser, I., Guillon, J.C., Bandu, M.T., Ronco, P., Morel-Maroger, L., and Verroust, P. (1980). Severity of lymphocytic choriomeningitis virus disease in different strains of suckling mice correlates with increasing amounts of endogenous interferon. J. Exp. Med. 152: 633-640. 53. Pfau, C.J., Gresser, I., and Hunt, K.D. (1983). Lethal role of interferon in lymphocytic choriomeningitis virus-induced encephalitis. J. Gen. Virol. 64: 1827-30. 54. Minato, N., Reid, L., Neighbor, A., Bloom, B., and Holland, J. (1984). Interferon, NK cells and persistent virus infection. Li: Concepts in viral pathogenesis, edited by A.L. Notkins, and M.B.A. Oldstone, Springer-Verlag, New York. 42-52. 55. Perussia, B., Santoli, D., and Trinchieri, G. (1984). Interferon modulation of natural killer cell activity. Li: Concepts in viral pathogenesis, edited by A.L. Notkins and M.B.A. Oldstone, Springer-Verlag, New York, 55-62. 56. Anderson, M.J. (1982). The role of interferon in the NK cell killing of virus-infected target cells. J. Hyg. (London). 89: 347-351. 57. Fitzgerald, P.A., Mendelsohn, M., Lopez, C. (1985). Human natural killer cells limit replication of herpes simplex virus type 1 in_ vitro. J. Immunol. 134: 2666-72. 58. Bukowski, J.F., Woda, B.A., and Welsh, R.M. (1984). Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J. Virol. 52: 119-28. 59. Habu, S., Akamatsu, K., Tamaoki, N., and Okumura, K. (1984). In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice. J. Immunol. 133: 2743-47. 60. Cooper, N. (1984). The role of complement system in host defense against virus diseases. _In: Concepts in viral pathogenesis, edited by A.L. Notkins and M.B.A. Oldstone, Springer-Verlag, New York, 20-25. 61. Hirsch, R.L., Winkelstein, J.A., and Griffin, D.E. (1980). The role of complement in viral infections. J. Immunol. 124: 2507-10. 73. Yap, K.L., and Ada, G.L. (1978). The recovery of mice from influenza virus infection: adoptive transfer of immunity with immune T lymphocytes. Scand. J. Immunol. 7: 389-97. 74. Wells, M.A, Daniel, S., Djeu, J.Y., Kiley, S.C., Ennis, F.A. (1983). Recovery from a viral respiratory tract infection. IV. Specificity of protection by cytotoxic T lymphocytes. J. Immunol. 130: 2908-14. 75. Gerhard, W. and Koprowski, H. (1984). Monoclonal antibodies. Li: Concepts in viral pathogenesis, edited by A.L. Notkins and M.B.A. Oldstone, Springer-Verlag, New York, 376-81. 76. Mathews, J.H., Roehrig, J.T. (1984). Elucidation of the topography and determination of the protective epitopes on the E glycoprotein of Saint Louis encephalitis virus by passive transfer with monoclonal antibodies. J. Immunol. 132: 1533-37. 77. Roehrig, J.T., Mathews, J.H. (1985). The neutralization site on the E2 glycoprotein of Venezuelan equine encephalitis (TC-83) virus is composed of multiple conformationally stable epitopes. Virology 142: 347-56. 78. Hunt, A.R., Roehrig, J.T. (1985). Biochemical and biological characteristics of epitopes on the El glycoprotein of Western equine encephalitis virus. Virology 142: 334-46. 79. Wolinsky, J.S., Waxham, M.N., Server, A.C. (1985). Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis. J. Virol. 53: 727-34. 80. Mathews, J.H., and Roehrig, J.T. (1982). Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies. J. of Immunol. 129: 2763-67. 81. Dix, R.D., Pereira, L. and Baringer, J.R. (1981). Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus induced neurological disease. Infection and Immunity, 34: 192-99. 82. Buchmeier, M.J., Lewicki, H.A., Talbot, P.J., and Knobler, R.L. (1984). Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virol. 132: 261-270. 83. Boere, W.M., Benaisso-Trouw, B.J., Harmsen, M., Kraaijeveld, CA., and Snippe, H. (1983). Neutralizing and non-neutralizing monoclonal antibodies to the",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "III. IMMUNOSUPPRESSION: THE ROLE OF THE IMMUNE RESPONSE IN THE RECOVERY FROM PRIMARY VIRAL INFECTION",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "cytolytic T cells. (Mysteriously, these animals survive the clearance process without destruction of irreplaceable neurons.)A considerable number of animal viruses have been shown to initiate immunopathologies.",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "The tentative interpretation was that MHV had initiated EAE; if correct, it remains to determine whether molecular mimicry, release of immunogenic BP secondary to viral demyelination, or some other mechanism is responsible\u00b7 V. CONCLUSION: IMPLICATION FOR THE USE OF RODENTS IN BIOMEDICAL EXPERIMENTATION Enzootic infections with various murine viruses are widespread in animal facilities used for biom\u00e9dical research, as documented in other chapters in this monograph\u00b7 This means that any immunological studies which involve immunosuppression may be complicated by the inadvertent potentiation of indigenous, often unsuspected, viruses. (Although outside the scope of this short review, it should be noted that intercurrent infection may also confound immunobiologic studies which do not employ suppression.)",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}